Literature DB >> 795481

Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.

A W Nienhuis, C Delea, R Aamodt, F Bartter, W F Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 795481

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN： 0547-6844


× No keyword cloud information.
  3 in total

1.  Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.

Authors:  B S van Asbeck; J H Marcelis; J J Marx; A Struyvenberg; J H van Kats; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

2.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04

3.  Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.

Authors:  B S van Asbeck; J H Marcelis; J H van Kats; E Y Jaarsma; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.